John H. Alexander, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Portola(SIGNIFICANT), Pfizer Inc(SIGNIFICANT), Veralox(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Humacyte(MODEST), Antev(MODEST) RESEARCH/RESEARCH GRANTS: Bristol Myers Squibb(SIGNIFICANT), CSL Behring (SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Artivion(SIGNIFICANT)

View Full Disclosure